(c) 2024 PillSync.com

Canada varenicline tartrate 1 mg

INDICATIONS & USAGE: Hypersensitivity to hydrocodone or acetaminophen...Known or suspected gastrointestinal obstruction...Acute or severe bronchial asthma in an unmonitored setting...Significant respiratory depression...respiratory depression by direct action on brain stem respiratory centers...risks of addiction, abuse, and misuse...management of pain...Neonatal Opioid Withdrawal Syndrome...selective beta1-adrenoreceptor blocking agent...clinical trials performed in support of efficacy were 4 to 5 weeks in duration...short-term treatment of insomnia...hypersensitive to other opioids may exhibit cross-sensitivity to hydrocodone...relief of moderate to moderately severe pain...Acetaminophen has been associated with cases of acute liver failure...relief of moderate to moderately severe pain...Myocardial Infarction...reduce cardiovascular mortality...Angina Pectoris...Hypertension...


4 years ago   oval blue WPI 199 Canada varenicline tartrate 1 mg

oval blue WPI 199

Comments












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site